[Absence of cataractogenic effect of 0.03 percent phospholine iodide].
作者信息
Corbel M, Leser C, Lemaire E
出版信息
Bull Soc Ophtalmol Fr. 1971 Sep-Oct;71(9):885-9.
PMID:5151034
Abstract
摘要
相似文献
1
[Absence of cataractogenic effect of 0.03 percent phospholine iodide].
Bull Soc Ophtalmol Fr. 1971 Sep-Oct;71(9):885-9.
2
Incidence of lens changes in patients treated with echothiophate iodide.
Arch Ophthalmol. 1968 Sep;80(3):317-20. doi: 10.1001/archopht.1968.00980050319004.
3
Effect of echothiophate iodide on the lens.
Am J Ophthalmol. 1969 Dec;68(6):1003-10. doi: 10.1016/0002-9394(69)93440-0.
4
Lens opacities in glaucoma patients on phospholine iodide therapy.
Trans Ophthalmol Soc U K (1962). 1966;86:89-100.
5
Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract.
Acta Ophthalmol (Copenh). 1968;46(1):83-98.
6
[Phospholine iodide and opacity of the lens].
Ned Tijdschr Geneeskd. 1968 Oct 19;112(42):1898-901.
7
[Phospholine iodide and the lens].
Harefuah. 1973 Dec 16;85(12):572-4.
8
Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy.
Acta Ophthalmol (Copenh). 1969;47(4):1049-56. doi: 10.1111/j.1755-3768.1969.tb03730.x.
9
Uniocular miotic therapy.
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975 Mar-Apr;79(2):OP376-80.
10
Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine.
Acta Ophthalmol (Copenh). 1968;46(4):831-45. doi: 10.1111/j.1755-3768.1968.tb02883.x.
Zotero 插件